Archive for category: Industry

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

/ August 22, 2017 8:32 am

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent Office (EPO) has issued an Intent to Grant notice related to Thymosin beta 4 […]

Suven Life secures Process Patents in Europe, Japan and New Zealand

Suven Life secures Process Patents in Europe, Japan and New Zealand

/ August 17, 2017 8:16 am

Suven Life Sciences Ltd (Suven) announces today that the grant of of one (1) process patent from Europe (3077375), one (1) process patent from Japan (6151453) and one (1) process patent from New Zealand (719671) corresponding to the New Chemical Entities (NCEs) which […]

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

/ August 10, 2017 9:50 am

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favourable outcomes anticipated Darmstadt, Germany, August 3, 2017 — Merck, a leading […]

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

/ August 4, 2017 8:00 am

AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), announced that it has received grant status for the patent application: PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN-B IN PLANTS (EP3013963) from the European Patent Office. Exogenous pulmonary surfactant is routinely being used in surfactant […]

Cellectis Granted Patent for CRISPR Use in T-Cells

Cellectis Granted Patent for CRISPR Use in T-Cells

/ July 26, 2017 9:15 am

Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such […]

AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033

AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033

/ July 13, 2017 8:20 am

AB Science SA (NYSE Euronext – FR0010557264 – AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), today announced that the patent offices of Europe (EP13 773 731.8), Singapore (11201502626P) and South Africa […]

InDex Pharmaceuticals gets new patent granted in Europe

InDex Pharmaceuticals gets new patent granted in Europe

/ July 13, 2017 8:13 am

July 6, 2017 – Index Pharmaceuticals Holding AB (publ) today announced that a new use patent for the drug candidate cobitolimod granted by the European Patent Office. The patent provides additional protection for the use of cobitolimod for the treatment of […]

EPO and IRENA enhance cooperation on patent information about renewable energy technologies

EPO and IRENA enhance cooperation on patent information about renewable energy technologies

/ July 4, 2017 10:00 am

Munich, 3 July 2017 - The International Renewable Energy Agency (IRENA) and the EPO have signed a Memorandum of Understanding on bilateral cooperation to promote innovation in the field of renewable energy technologies. The agreement enhances the co-operation between the two […]

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

/ July 4, 2017 9:57 am

<< Back CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing – Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE NEWSWIRE) – CRISPR Therapeutics (NASDAQ:CRSP) reported […]

Are you looking to strengthen your IP team?

Are you looking to strengthen your IP team?

/ June 28, 2017 9:15 am

Are you looking to strengthen your IP team? ========== EPA – Insight provides an unrivaled reach into the patent attorney market to help fill your open positions. From advertising on the website to a full search and selection process you […]